Pseudomonas aeruginosa population structure revisited

PLoS ONE

Volumn 4, Issue 11, 2009, Pages

  Pirnay, Jean Paul ^a   Bilocq, Florence ^a   Pot, Bruno ^b   Cornelis, Pierre ^c   Zizi, Martin ^c   Van Eldere, Johan ^d   Deschaght, Pieter ^e   Vaneechoutte, Mario ^e   Jennes, Serge ^a   Pitt, Tyrone ^f   De Vos, Daniel ^a,c  

^a QUEEN ASTRID MILITARY HOSPITAL   (Belgium)

^b Applied Maths ^*  (Belgium)

^c VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^d REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^e GHENT UNIVERSITY   (Belgium)

^f PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; PROTEIN EXOS; PROTEIN EXOU; PROTEIN FPVA; PROTEIN FPVB; PROTEIN OPRD; PROTEIN OPRL; UNCLASSIFIED DRUG;

AMPLIFIED FRAGMENT LENGTH POLYMORPHISM; ARTICLE; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM ISOLATE; CYSTIC FIBROSIS; ENVIRONMENTAL FACTOR; FLUORESCENCE; GENE FREQUENCY; GENE LOCATION; GENE SEQUENCE; GENOTYPE; MICROHABITAT; MULTIDRUG RESISTANCE; NONHUMAN; POPULATION DISTRIBUTION; POPULATION STRUCTURE; PSEUDOMONAS AERUGINOSA; SEROTYPE; ANIMAL; BACTERIAL GENE; BACTERIAL GENOME; BACTERIUM IDENTIFICATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC RECOMBINATION; GENETIC VARIABILITY; HUMAN; METABOLISM; MICROBIOLOGY; POLYMERASE CHAIN REACTION; PSEUDOMONAS INFECTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ANIMALIA; PSEUDOMONAS AERUGINOSA;

ANIMALS; BACTERIAL TYPING TECHNIQUES; CYSTIC FIBROSIS; DRUG RESISTANCE, MULTIPLE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, BACTERIAL; GENES, BACTERIAL; GENETIC VARIATION; GENOME, BACTERIAL; HUMANS; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RECOMBINATION, GENETIC;

EID: 70849094620     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0007740     Document Type: Article

References (119)

1. Gessard C (1882) Sur les colorations bleue et verte des linges à pansements. Comptes-rendus hebdomadaire des séances de l'Académie des Sciences 94: 536-538.
2. Goldberg JB (2000) Pseudomonas: global bacteria. Trends Microbiol 8: 55-57.
3. Römling U, Wingender J, Müller H, Tümmler B (1994) A major Pseudomonas aeruginosa clone common to patients and aquatic habitats. Appl Environ Microbiol 60: 1734-1738.
4. Rahme LG, Stevens EJ, Wolfort SF, Shao J, Tompkins RG, et al. (1995) Common virulence factors for bacterial pathogenicity in plants and animals. Science 268: 1899-1902.
5. Foght JM, Westlake DWS, Johnson WM, Ridgway HF (1996) Environmental gasoline-utilizing isolates of Pseudomonas aeruginosa are taxonomically indistinguishable by chemotaxonomic and molecular techniques. Microbiology 142: 2333-2340.
6. Alonso A, Rojo F, Martinez JL (1999) Environmental and clinical isolates of Pseudomonas aeruginosa show pathogenic and biodegradative properties irrespective of their origin. Environ Microbiol 1: 421-430.
7. Maynard Smith J, Smith NH, O'Rourke M, Spratt BG (1993) How clonal are bacteria? Proc Natl Acad Sci U S A 90: 4384-4388.
8. Denamur E, Picard B, Decoux G, Denis JB, Elion J (1993) The absence of correlation between allozyme and rrn RFLP analysis indicates a high gene flow rate within human clinical Pseudomonas aeruginosa isolates. FEMS Microbiol Lett 110: 275-280.
9. Picard B, Denamur E, Barakat A, Elion J, Goullet P (1994) Genetic heterogenicity of Pseudomonas aeruginosa clinical isolates revealed by esterase electrophoretic polymorphism and restriction fragment length polymorphism of the ribosomal RNA gene region. J Med Microbiol 40: 313-322.
10. Kiewitz C, Tümmler B (2000) Sequence diversity of Pseudomonas aeruginosa: impact on population structure and genome evolution. J Bacteriol 182: 3125-3135.
11. Ruimy R, Genauzeau E, Barnabe C, Beaulieu A, Tibayrenc M, et al. (2001) Genetic diversity of Pseudomonas aeruginosa strains isolated from ventilated patients with nosocomial pneumonia, cancer patients with bacteremia, and environmental water. Infect Immun 69: 584-588.
12. Lomholt JA, Poulsen K, Kilian M (2001) Epidemic population structure of Pseudomonas aeruginosa: evidence for a clone that is pathogenic to the eye and that has a distinct combination of virulence factors. Infect Immun 69: 6284-6295.
13. Pirnay JP, De Vos D, Cochez C, Bilocq F, Vanderkelen A, et al. (2002) Pseudomonas aeruginosa displays an epidemic population structure. Environ Microbiol 4: 898-911.
14. Curran B, Jonas D, Grundmann H, Pitt T, Dowson CG (2004) Development of a multilocus sequence typing scheme for the opportunistic pathogen Pseudomonas aeruginosa. J Clin Microbiol 42: 5644-5649.
15. Pirnay JP, Matthijs S, Colak H, Chablain P, Bilocq F, et al. (2005) Global Pseudomonas aeruginosa biodiversity as reflected in a Belgian river. Environ Microbiol 7: 969-980.
16. Spencer DH, Kas A, Smith EE, Raymond CK, Sims EH, et al. (2003) Whole-genome sequence variation among multiple isolates of Pseudomonas aeruginosa. J Bacteriol 185: 1316-1325.
17. Wolfgang MC, Kulasekara BR, Liang X, Boyd D, Wu K, et al. (2003) Conservation of genome content and virulence determinants among clinical and environmental isolates of Pseudomonas aeruginosa. Proc Natl Acad Sci U S A 100: 8484-8489.
18. He J, Baldini RL, Déziel E, Saucier M, Zhang Q, et al. (2004) The broad host range pathogen Pseudomonas aeruginosa strain PA14 carries two pathogenicity islands harboring plant and animal virulence genes. Proc Natl Acad Sci U S A 101: 2530-2535.
19. Morales G, Wiehlmann L, Gudowius P, van Delden C, Tümmler B, et al. (2004) Structure of Pseudomonas aeruginosa populations analyzed by single nucleotide polymorphism and pulsed-field gel electrophoresis genotyping. J Bacteriol 186: 4228-4237.
20. Mathee K, Narasimhan G, Valdes C, Qiu X, Matewish JM, et al. (2008) Dynamics of Pseudomonas aeruginosa genome evolution. Proc Natl Acad Sci U S A 105: 3100-3105.
21. Shen K, Sayeed S, Antalis P, Gladitz J, Ahmed A, et al. (2006) Extensive genomic plasticity in Pseudomonas aeruginosa revealed by identification and distribution studies of novel genes among clinical isolates. Infect Immun 74: 5272-5283.
22. Ripp S, Ogunseitan OA, Miller RV (1994) Transduction of a freshwater microbial community by a new Pseudomonas aeruginosa generalized transducing phage, UT1. Mol Ecol 3: 121-126.
23. Lee DG, Urbach JM, Wu G, Liberati NT, Feinbaum RL, et al. (2006) Genomic analysis reveals that Pseudomonas aeruginosa virulence is combinatorial. Genome Biol 7: R90.
24. Wiehlmann L, Wagner G, Cramer N, Siebert B, Gudowius P, et al. (2007) Population structure of Pseudomonas aeruginosa. Proc Natl Acad Sci U S A 104: 8101-8106.
25. Farmer JJ 3rd, Weinstein RA, Zierdt CH, Brokopp CD (1982) Hospital outbreaks caused by Pseudomonas aeruginosa: Importance of serogroup O11. J Clin Microbiol 16: 266-270.
26. Giammanco A, Di Stefano R, Arista S, Sinatra A, Chiarini A (1985) Infections caused by Pseudomonas aeruginosa: relatively frequent isolation of serogroup 12 from clinical specimens. Eur J Epidemiol 1: 104-109.
27. Legakis NJ, Koukoubanis N, Malliara K, Michalitsianos D, Papavassiliou J (1987) Importance of carbenicillin and gentamicin cross-resistant serotype O:12 Pseudomonas aeruginosa in six Athens hospitals. Eur J Clin Microbiol 6: 300-303.
28. Pitt TL, Livermore DM, Pitcher D, Vatopoulos AC, Legakis NJ (1989) Multiresistant serotype O12 Pseudomonas aeruginosa: evidence for a common strain in Europe. Epidemiol Infect 103: 565-576.
29. Grattard F, Gaudin OG, Pozzetto B, Ros A, Mbida AD (1993) Genotypic homogeneity of nosocomial Pseudomonas aeruginosa O12 strains demostrated by analysis of protein profiles, DNA fingerprints and rRNA gene restriction patterns. Eur J Clin Microbiol Infect Dis 12: 57-61.
30. Tsakris A, Vatopoulos AC, Tzouvelekis LS, Legakis NJ (1992) Diversity of resistance phenotypes and plasmid analysis in multi-resistant O:12 Pseudomonas aeruginosa. Eur J Epidemiol 8: 865-870.
31. Elaichouni A, Verschraegen G, Claeys G, Devleeschouwer M, Godard C, et al. (1994) Pseudomonas aeruginosa serotype O12 outbreak studied by arbitrary primer PCR. J Clin Microbiol 32: 666-671.
32. Richard P, Le Floch R, Chamoux C, Pannier M, Espaze E, et al. (1994) Pseudomonas aeruginosa outbreak in a burn unit: role of antimicrobials in the emergence of multiply resistant strains. J Infect Dis 170: 377-383.
33. Kettner M, Milosovic P, Hletková M, Kallová J (1995) Incidence and mechanisms of aminoglycoside resistance in Pseudomonas aeruginosa serotype O11 isolates. Infection 23: 380-383.
34. Bingen E, Bonacorsi S, Rohrlich P, Duval M, Lhopital S, et al. (1996) Molecular evidence of genotypic heterogeneity of multidrug-resistant Pseudomonas aeruginosa serotype O:12 outbreak isolates from a pediatric hospital. J Clin Microbiol 34: 3226-3229.
35. Mifsud AJ, Watine J, Picard B, Charet JC, Solignac-Bourrel C, et al. (1997) Epidemiologically related and unrelated strains of Pseudomonas aeruginosa serotype O12 cannot be distinguished by phenotypic and genotypic typing. J Hosp Infect 36: 105-116.
36. Tassios PT, Gennimata V, Maniatis AN, Fock C, Legakis NJ, et al. (1998) Emergence of multidrug resistance in ubiquitous and dominant Pseudomonas aeruginosa serogroup O:11. J Clin Microbiol 36: 897-901.
37. Watine J, Hacini J, Vidal I (1999) Is there a connection between prolonged carriage and clonal hospital-to-hospital clonal spread of multiresistant Pseudomonas aeruginosa of the O12 serotype? Are the specific habits of the hospitals involved the cause? Pathol Biol (Paris) 47: 457-461.
38. Müller-Premru M, Gubina M (2000) Serotype, antimicrobial susceptibility and clone distribution of Pseudomonas aeruginosa in a university hospital. Zentralbl Bakteriol 289: 857-867.
39. Dubois V, Arpin C, Melon M, Melon B, Andre C, et al. (2001) Nosocomial outbreak due to a multiresistant strain of Pseudomonas aeruginosa P12: efficacy of cefepime-amikacin therapy and analysis of b-lactam resistance. J Clin Microbiol 39: 2072-2078.
40. Loureiro MM, de Moraes BA, Mendonca VL, Quadra MR, Pinheiro GS, et al. (2002) Pseudomonas aeruginosa: study of antibiotic resistance and molecular typing in hospital infection cases in a neonatal intensive care unit from Rio de Janeiro City, Brazil. Mem Inst Oswaldo Cruz 97: 387-394.
41. Pirnay JP, De Vos D, Cochez C, Bilocq F, Pirson J, et al. (2003) Molecular epidemiology of Pseudomonas aeruginosa colonization in a burn unit: persistence of a multidrug-resistant clone and a silver sulfadiazine-resistant clone. J Clin Microbiol 41: 1192-1202.
42. Crespo MP, Woodford N, Sinclair A, Kaufmann ME, Turton J, et al. (2004) Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-8, a novel metallo-beta-lactamase, in a tertiary care center in Cali, Colombia. J Clin Microbiol 42: 5094-5101.
43. Deplano A, Denis O, Poirel L, Hocquet D, Nonhoff C, et al. (2005) Molecular characterization of an epidemic clone of panantibiotic-resistant Pseudomonas aeruginosa. J Clin Microbiol 43: 1198-1204.
44. Riccio ML, Pallecchi L, Docquier JD, Cresti S, Catania MR, et al. (2005) Clonal relatedness and conserved integron structures in epidemiologically unrelated Pseudomonas aeruginosa strains producing the VIM-1 metallo-β-lactamase from different Italian hospitals. Antimicrob Agents Chemother 49: 104-110.
45. Sekiguchi J, Asagi T, Miyoshi-Akiyama T, Kasai A, Mizuguchi Y, et al. (2007) Outbreaks of multidrug-resistant Pseudomonas aeruginosa in community hospitals in Japan. J Clin Microbiol 45: 979-989.
46. Hammami S, Ghozzi R, Burghoffer B, Arlet G, Redjeb S (2008) Mechanisms of carbapenem resistance in non-metallo-beta-lactamase-producing clinical isolates of Pseudomonas aeruginosa from a Tunisian hospital. Pathol Biol (Paris) Oct 30 [Epub ahead of print].
47. Libisch B, Watine J, Balogh B, Gacs M, Muzslay M, et al. (2008) Molecular typing indicates an important role for two international clonal complexes in dissemination of VIM-producing Pseudomonas aeruginosa clinical isolates in Hungary. Res Microbiol 159: 162-168.
48. Cheng K, Smyth RL, Govan JRW, Doherty C, Winstanley C, et al. (1996) Spread of β-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic. Lancet 348: 639-642.
49. Fluge G, Ojeniyi B, Høiby N, Digranes A, Ciofu O, et al. (2001) Typing of Pseudomonas aeruginosa strains in Norwegian cystic fibrosis patients. Clin Microbiol Infect 7: 238-243.
50. Jones AM, Govan JRW, Doherty CJ, Dodd ME, Isalska BJ, et al. (2001) Sprea of a multiresistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis clinic. Lancet 358: 557-558.
51. McCallum SJ, Corkill J, Gallagher M, Ledson MJ, Hart CA, Walshaw MJ (2001) Superinfection with a transmissible strain of Pseudomonas aeruginosa in adults with cystic fibrosis chronically colonised by P. aeruginosa. Lancet 358: 558-560.
52. Anthony M, Rose B, Pegler MB, Elkins M, Service H, et al. (2002) Genetic analysis of Pseudomonas aeruginosa isolates from the sputa of Australian adult cystic fibrosis patients. J Clin Microbiol 40: 2772-2778.
53. Armstrong D, Bell S, Robinson M, Bye P, Rose B, et al. (2003) Evidence for spread of a clonal strain of Pseudomonas aeruginosa among cystic fibrosis clinics. J Clin Microbiol 41: 2266-2267.
54. O'Carroll MR, Syrmis MW, Wainwright CE, Greer RM, Mitchell P, et al. (2004) Clonal strains of Pseudomonas aeruginosa in paediatric and adult cystic fibrosis units. Eur Respir J 24: 101-106.
55. Scott F, Pitt TL (2004) Identification and characterization of transmissible Pseudomonas aeruginosa strains in cystic fibrosis patients in England and Wales. J Med Microbiol 53: 609-615.
56. Chambers D, Scott F, Bangur R, Davies R, Lim A, et al. (2005) Factors associated with infection by Pseudomonas aeruginosa in adult cystic fibrosis. Eur Respir J 26: 651-656.
57. Lewis DA, Jones A, Parkhill J, Speert DP, Govan JRW, et al. (2005) Identification of DNA markers for a transmissible Pseudomonas aeruginosa cystic fibrosis strain. Am J Respir Cell Mol Biol 33: 56-64.
58. Jelsbak L, Johansen HK, Frost AL, Thogersen R, Thomsen LE, et al. (2007) Molecular epidemiology and dynamics of Pseudomonas aeruginosa populations in lungs of cystic fibrosis patients. Infect Immun 75: 2214-2224.
59. Bradbury R, Champion A, Reid DW (2008) Poor clinical outcomes associated with a multi-drug resistant clonal strain of Pseudomonas aeruginosa in the Tasmanian cystic fibrosis population. Respirology 13: 886-892.
60. Brimicombe RW, Dijkshoorn L, van der Reijden TJ, Kardoes I, Pitt TL, et al. (2008) Transmission of Pseudomonas aeruginosa in children with cystic fibrosis attending summer camps in The Netherlands. J Cyst Fibros 7: 30-36.
61. van Belkum A (1996) Current trends in typing of bacterial strains for medical purposes. Zentralbl Bakteriol 1045: 249-252.
62. Vandamme P, Pot B, Gillis M, de Vos P, Kersters K, et al. (1996) Polyphasic taxonomy, a consensus approach to bacterial systematics. Microbiol Rev 60: 407-438.
63. Aoki K (1926) Agglutinatorische einteilung von Pyocyaneus-bazillen welche bei verschiedenen menschenerkrangungen nach gewiesen wurden. Zentralbl Bakteriol Parasitenkd Infectionskr Hyg Abt 1 Orig 98: 186-195.
64. Vos P, Hogers R, Bleeker M, Reijans M, van de Lee T, et al. (1995) AFLP: a new technique for DNA fingerprinting. Nucleic Acids Res 23: 4407-4414.
65. Janssen P, Coopman R, Huys G, Swings J, Bleeker M, et al. (1996) Evaluation of the DNA fingerprinting method AFLP as a new tool in bacterial taxonomy. Microbiology 142: 1881-1893.
66. Savelkoul PHM, Aarts HJM, de Haas J, Dijkshoorn L, Duim B, et al. (1999) Amplified-fragment length polymorphism analysis: the state of an art. J Clin Microbiol 37: 3083-3091.
67. Spratt BG, Maiden MCJ (1999) Bacterial population genetics, evolution and epidemiology. Phil Trans R Soc Lond 354: 701-710.
68. Cornelis P, Bouia A, Belarbi A, Guyonvarch A, Kammerer B, et al. (1989) Cloning and analysis of the gene for the major outer membrane lipoprotein from Pseudomonas aeruginosa. Mol Microbiol 3: 421-428.
69. Lim A Jr, De Vos D, Brauns M, Mossialos D, Gaballa A, et al. (1997) Molecular and immunological characterization of OprL, the 18 kDa outer-membrane peptidoglycan-associated lipoprotein (PAL) of Pseudomonas aeruginosa. Microbiology 143: 1709-1716.
70. De Vos D, Lim A Jr, Pirnay JP, Struelens M, Vandenvelde C, et al. (1997) Direct detection and identification of Pseudomonas aeruginosa in clinical samples such as skin biopsy specimens and expectorations by multiplex PCR based on two outer membrane lipoprotein genes, oprI and oprL. J Clin Microbiol 35: 1295-1299.
71. De Vos D, Bouton C, Sarniguet A, De Vos P, Vauterin M, et al. (1998) Sequence diversity of the oprI gene, coding for major outer membrane lipoprotein I, among rRNA group I pseudomonads. J Bacteriol 180: 6551-6556.
72. Trias J, Nikaido H (1990) Outer membrane protein D2 catalyzes facilitated diffusion of carbapenems and penems through the outer membrane of Pseudomonas aeruginosa. Antimicrob Agents Chemother 34: 52-57.
73. Trias J, Nikaido H (1990) Protein D2 channel of the Pseudomonas aeruginosa outer membrane has a binding site for basic amino acids and peptides. J Biol Chem 265: 15680-15684.
74. Pirnay JP, De Vos D, Mossialos D, Vanderkelen A, Cornelis P, et al. (2002) Analysis of the Pseudomonas aeruginosa oprD gene from clinical and environmental isolates. Environ Microbiol 4: 872-882.
75. Meyer JM (2000) Pyoverdines: pigments, siderophores and potential taxonomic markers of fluorescent Pseudomonas species. Arch Microbiol 174: 135-142.
76. Cornelis P, Hohnadel D, Meyer JM (1989) Evidence for different pyoverdine-mediated iron uptake systems among Pseudomonas aeruginosa strains. Infect Immun 57: 3491-3497.
77. Meyer JM, Stintzi A, De Vos D, Cornelis P, Tappe R, et al. (1997) Use of siderophores to type pseudomonads: the three Pseudomonas aeruginosa pyoverdine systems. Microbiology 143: 35-43.
78. de Chial M, Ghysels B, Beatson SA, Geoffroy V, Meyer JM, et al. (2003) Identification of type II and type III pyoverdine receptors from Pseudomonas aeruginosa. Microbiology 149: 821-831.
79. Tümmler B, Cornelis P (2005) Pyoverdine receptor: a case of positive Darwinian selection in Pseudomonas aeruginosa. J Bacteriol 187: 3289-3292.
80. Smith EE, Sims EH, Spencer DH, Kaul R, Olson MV (2005) Evidence for diversifying selection at the pyoverdine locus of Pseudomonas aeruginosa. J Bacteriol 187: 2138-2147.
81. Bodilis J, Ghysels B, Osayande J, Matthijs S, Pirnay JP, et al. (2009) Distribution and evolution of ferripyoverdine receptors in Pseudomonas aeruginosa. Environ Microbiol. 2009 Apr 21.
82. Ghysels B, Dieu BT, Beatson SA, Pirnay JP, Ochsner UA, et al. (2004) FpvB, an alternative type I ferripyoverdine receptor of Pseudomonas aeruginosa. Microbiology 150: 1671-1680.
83. Schulert GS, Feltman H, Rabin SD, Martin CG, Battle SE, et al. (2003) Secretion of the toxin ExoU is a marker for highly virulent Pseudomonas aeruginosa isolates obtained from patients with hospital-acquired pneumonia. J Infect Dis 188: 1695-1706.
84. Lin HH, Huang SP, Teng HC, Ji DD, Chen YS, et al. (2006) Presence of the exoU gene of Pseudomonas aeruginosa is correlated with cytotoxicity in MDCK cells but not with colonization in BALB/c mice. J Clin Microbiol 44: 4596-4597.
85. Castric P (1995) pilO, a gene required for glycosylation of Pseudomonas aeruginosa 1244 pilin. Microbiology 141: 1247-1254.
86. Kus JV, Tullis E, Cvitkovitch DG, Burrows LL (2004) Significant differences in type IV pilin allele distribution among Pseudomonas aeruginosa isolates from cystic fibrosis (CF) versus non-CF patients. Microbiology 150: 1315-1326.
87. Hancock RE, Mutharia LM, Chan L, Darveau RP, Speert DP, et al. (1983) Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypable strains deficient in lipopolysaccharide O side chains. Infect Immun 42: 170-177.
88. Pitt TL, MacDougall J, Penketh AR, Cooke EM (1986) Polyagglutinating and non-typable strains of Pseudomonas aeruginosa in cystic fibrosis. J Med Microbiol 21: 179-186.
89. Penketh A, Pitt T, Roberts D, Hodson ME, Batten JC (1983) The relationship of phenotype changes in Pseudomonas aeruginosa to the clinical condition of patients with cystic fibrosis. Am Rev Respir Dis 127: 605-608.
90. Zierdt CH, Williams RL (1975) Serotyping of Pseudomonas aeruginosa isolates from patients with cystic fibrosis of the pancreas. J Clin Microbiol 1: 521-526.
91. Bert F, Lambert-Zechovsky N (1996) Comparative distribution of resistance patterns and serotypes in Pseudomonas aeruginosa isolates from intensive care units and other wards. J Antimicrob Chemother 37: 809-813.
92. Kobayashi L, Hasegawa M, Miyazaki S, Nishida M, Goto S (1994) In vitro and in vivo changes of serotype in Pseudomonas aeruginosa isolates by anti-pseudomonal drugs. J Antibiot (Tokyo) 47: 72-79.
93. Kuzio J, Kropinski AM (1983) O-antigen conversion in Pseudomonas aeruginosa PAO1 by bacteriophage D3. J Bacteriol 155: 203-212.
94. Speijer H, Savelkoul PH, Bonten MJ, Stobberingh EE, Tjhie JH (1999) Application of different genotyping methods for Pseudomonas aeruginosa in a setting of endemicity in an intensive care unit. J Clin Microbiol 37: 3654-3661.
95. Tenover FC, Arbeit RD, Goering RV, Micklesen PA, Murray BE, et al. (1995) Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33: 2233-2239.
96. Fleiszig SM, Wiener-Kronish JP, Miyazaki H, Vallas V, Mostov KE, et al. (1997) Pseudomonas aeruginosa-mediated cytotoxicity and invasion correlate with distinct genotypes at the loci encoding exoenzyme S. Infect Immun 65: 579-586.
97. Hauser AR, Cobb E, Bodi M, Mariscal D, Vallés J, et al. (2002) Type III protein secretion is associated with poor clinical outcomes in patients with ventilator-associated pneumonia caused by Pseudomonas aeruginosa. Crit Care Med 30: 521-528.
98. Feltman H, Schulert G, Khan S, Jain M, Peterson L, et al. (2001) Prevalence of type III secretion genes in clinical and environmental isolates of Pseudomonas aeruginosa. Microbiology 147: 2659-2669.
99. Wareham DW, Curtis MA (2007) A genotypic and phenotypic comparison of type III secretion profiles of Pseudomonas aeruginosa cystic fibrosis and bacteremia isolates. Int J Med Microbiol 297: 227-234.
100. Ferguson MW, Maxwell JA, Vincent TS, da Silva J, Olson JC (2001) Comparison of the exoS gene and protein expression in soil and clinical isolates of Pseudomonas aeruginosa. Infect Immun 69: 2198-2210.
101. Olson JC, Fraylick JE, McGuffie EM, Dolan KM, Yahr TL, et al. (1999) Interruption of multiple cellular processes in HT-29 epithelial cells by Pseudomonas aeruginosa exoenzyme S. Infect Immun 67: 2847-2854.
102. Rocha CL, Coburn J, Rucks EA, Olson JC (2003) Characterization of Pseudomonas aeruginosa exoenzyme S as a bifunctional enzyme in J774A.1 macrophages. Infect Immun 71: 5296-5305.
103. Gallant CV, Raivio TL, Olson JC, Woods DE, Storey DG (2000) Pseudomonas aeruginosa cystic fibrosis clinical isolates produce exotoxin A with altered ADP-ribosyltransferase activity and cytotoxicity. Microbiology 146: 1891-1899.
104. Kulasekara BR, Kulasekara HD, Wolfgang MC, Stevens L, Frank DW, et al. (2006) Acquisition and evolution of the exoU locus in Pseudomonas aeruginosa. J Bacteriol 188: 4037-4050.
105. De Vos D, de Chial M, Cochez C, Jansen S, Tümmler B, et al. (2001) Study of pyoverdine type and production by Pseudomonas aeruginosa isolated from cystic fibrosis patients: prevalence of type II pyoverdine isolates and accumulation pyoverdine-negative mutations. Arch Microbiol 175: 384-388.
106. Baysse C, Meyer JM, Plesiat P, Geoffroy V, Michel-Briand Y, et al. (1999) Uptake of pyocin S3 occurs through the outer membrane ferripyoverdine type II receptor of Pseudomonas aeruginosa. J Bacteriol 181: 3849-3851.
107. Denayer S, Matthijs S, Cornelis P (2007) Pyocin S2 (Sa) kills Pseudomonas aeruginosa strains via the FpvA type I ferripyoverdine receptor. J Bacteriol 189: 7663-7668.
108. Vauterin L, Vauterin P (2006) Integrated databasing and analysis. In: Stackebrandt E, ed. Molecular identification, systematics, and population structure of prokaryotes. Berlin: Springer-Verlag. pp 141-217.
109. Schouls LM, van der Heide HG, Vauterin L, Vauterin P, Mooi FR (2004) Multiple-locus variable-number tandem repeat analysis of Dutch Bordetella pertussis strains reveals rapid genetic changes with clonal expansion during the late 1990s. J Bacteriol 186: 5496-5505.
110. Ragon M, Wirth T, Hollandt F, Lavenir R, Lecuit M, et al. (2008) A new perspective on Listeria monocytogenes evolution. PLoS Pathog 4: e1000146. doi:10.1371/journal.ppat.1000146.
111. Lanotte P, Watt S, Mereghetti L, Dartiguelongue N, Rastegar-Lari A, et al. (2004) Genetic features of Pseudomonas aeruginosa isolates from cystic fibrosis patients compared with those of isolates from other origins. J Med Microbiol 53: 73-81.
112. Pitt TL (2002) Cross infection of cystic fibrosis patients with Pseudomonas aeruginosa. Thorax 57: 921.
113. Van Daele SG, Franckx H, Verhelst R, Schelstraete P, Haerynck F, et al. (2005) Epidemiology of Pseudomonas aeruginosa in a cystic fibrosis rehabilitation centre. Eur Respir J 25: 474-481.
114. Allemeersch D, Beumer J, Devleeschouwer M, De Maeyer S, Dony J, et al. (1988) Marked increase of Pseudomonas aeruginosa serotype O12 in Belgium since 1982. Eur J Clin Microbiol Infect Dis 7: 265-269.
115. Finlay BJ (2002) Global dispersal of free-living microbial eukaryote species. Science 296: 1061-1063.
116. Réseau épidémiologique des utilisateurs du systeme SIR (2001) Are the prolonged carrier and interhospital clonal diffusion of serotype O12 multiresistant Pseudomonas aeruginosa connected? Pathol Biol (Paris) 49: 620-623.
117. Liu PV, Matsumoto H, Kusama H, Bergan T (1983) Survey of heat-stable, major somatic antigens of Pseudomonas aeruginosa. Int J Syst Bacteriol 33: 256-264.
118. Livermore DM, Struelens M, Amorim J, Baquero F, Bille J, et al. (2002) Multicentre evaluation of the VITEK 2 Advanced Expert System for interpretive reading of antimicrobial resistance tests. J Antimicrob Chemother 49: 289-300.
119. Amsterdam D (1991) Susceptibility testing of antimicrobials in liquid media. In: Lorian V, ed (1991) Antibiotics in laboratory medicine. Baltimore: Williams & Wilkins. pp 72-78.